Anti-PL-7/PL-12 antisynthetase syndrome associated with interstitial lung disease following SARS-COV-2 infection and vaccination: A case study review
Cumulative evidence suggests a link between specific autoimmune diseases (AD), including idiopathic inflammatory myopathies (IIM), and SARS-CoV-2 infection or COVID-19 vaccination. Anti-synthetase syndrome (ASS), a subset of IIM, is defined by the presence of autoantibodies against aminoacyl-tRNA synthetase (anti-ARS) and is strongly associated with interstitial lung disease (ILD), a major contributor to severe complications and reduced survival. We present four clinical cases of patients who developed autoantibodies against threonyl (PL-7) and alanyl (PL-12) synthetases associated with ASS-ILD shortly after SARS-CoV-2 infection or COVID-19 vaccination. Anti-ARS autoantibodies were identified using three complementary methods: immunoblotting, western blotting (WB) and the method considered the gold standard, immunoprecipitation (IP), which ensures accurate interpretation of results. The study highlights the clinical and pathogenic overlap between ASS-ILD and SARS-CoV-2-related lung involvement.Both conditions share similar high-resolution computed tomography (HRCT) patterns, including inflammation and pulmonary fibrosis (PF), driven by IFN-γ signaling, which complicates accurate diagnosis. Our results provide novel insights into the temporal association of SARS-CoV-2 and vaccine exposure with ASS-ILD, focusing on possible molecular mimicry between viral proteins and ARS molecules as a potential mechanism. Understanding the involvement of specific anti-ARS autoantibodies (PL-7 and PL-12) and the identification of genetic predispositions (HLA-B∗08:01 and HLA-DRB1∗03:01) in these patients may be key to underpinning these autoimmune manifestations. The study underscores the importance of a multidisciplinary approach and vigilant follow-up to optimize diagnosis and management. Further research is essential to elucidate the causal relationships and molecular mechanisms behind these observations.
Authors
- Silvia Sánchez‐Ramón (ORCID: https://orcid.org/0000-0001-9585-6167)
- Juan Luis Rodríguez Hermosa (ORCID: https://orcid.org/0000-0003-0552-2484)
- Cristina Vadillo (ORCID: https://orcid.org/0000-0002-0540-0033)
- Anaís Mariscal
- Laura García-Bravo
- José Carlos Plaza-Hernández
- Beatriz Mediero Valeros
- Gloria Candelas (ORCID: https://orcid.org/0000-0001-7759-5127)
- Ángela Villegas
- M.A. Nieto Barbero
- Juliana Ochoa‐Grullón (ORCID: https://orcid.org/0000-0002-5218-7108)
- Miguel Fernández‐Arquero (ORCID: https://orcid.org/0009-0007-6213-6789)
- María G. Guzmán (ORCID: https://orcid.org/0000-0001-6161-9489)
- Bárbara López Uceda
Institutions
- Hospital de Sant Pau (ES)
- Hospital Clínico San Carlos (ES)
- Pathological Society (GB)
Publication Details
- Journal
- Heliyon
- Published
- 2024-12-30
- DOI
- https://doi.org/10.1016/j.heliyon.2024.e41311
- Citations
- 1
- Primary Topic
- Inflammatory Myopathies and Dermatomyositis
- Type
- article
- Field-Weighted Citation Impact
- 0.39